Found 404 results
Wieland A, Shashidharamurthy R, Kamphorst AO, Han J-H, Aubert RD, Choudhury BP, Stowell SR, Lee J, Punkosdy GA, Shlomchik MJ et al..  2015.  Antibody effector functions mediated by Fcγ-receptors are compromised during persistent viral infection.. Immunity. 42(2):367-78.
Burton DR, Mascola JR.  2015.  Antibody responses to envelope glycoproteins in HIV-1 infection.. Nat Immunol. 16(6):571-6.
Lee WShi, Richard J, Lichtfuss M, Smith AB, Park J, Courter JR, Melillo BN, Sodroski JG, Kaufmann DE, Finzi A et al..  2015.  Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells.. J Virol. 90(4):2021-30.
He L, Cheng Y, Kong L, Azadnia P, Giang E, Kim J, Wood MR, Wilson IA, Law M, Zhu J.  2015.  Approaching rational epitope vaccine design for hepatitis C virus with meta-server and multivalent scaffolding.. Sci Rep. 5:12501.
Hatzi K, J Nance P, Kroenke MA, Bothwell M, Haddad EK, Melnick A, Crotty S.  2015.  BCL6 orchestrates Tfh cell differentiation via multiple distinct mechanisms.. J Exp Med. 212(4):539-53.
Crotty S.  2015.  A brief history of T cell help to B cells.. Nat Rev Immunol. 15(3):185-9.
Radebe M, Gounder K, Mokgoro M, Ndhlovu ZM, Mncube Z, Mkhize L, van der Stok M, Jaggernath M, Walker BD, Ndung'u T.  2015.  Broad and persistent Gag-specific CD8+ T-cell responses are associated with viral control but rarely drive viral escape during primary HIV-1 infection.. AIDS. 29(1):23-33.
Richard J, Veillette M, Brassard N, Iyer SS, Roger M, Martin L, Pazgier M, Schön A, Freire E, Routy J-P et al..  2015.  CD4 mimetics sensitize HIV-1-infected cells to ADCC.. Proc Natl Acad Sci U S A. 112(20):E2687-94.
Pritchard LK, Harvey DJ, Bonomelli C, Crispin M, Doores KJ.  2015.  Cell- and Protein-Directed Glycosylation of Native Cleaved HIV-1 Envelope.. J Virol. 89(17):8932-44.
Schiffner T, de Val N, Russell RA, de Taeye SW, de la Peña ATorrents, Ozorowski G, Kim HJ, Nieusma T, Brod F, Cupo A et al..  2015.  Chemical Cross-Linking Stabilizes Native-Like HIV-1 Envelope Glycoprotein Trimer Antigens.. J Virol. 90(2):813-28.
Sharma SKumar, de Val N, Bale S, Guenaga J, Tran K, Feng Y, Dubrovskaya V, Ward AB, Wyatt RT.  2015.  Cleavage-Independent HIV-1 Env Trimers Engineered as Soluble Native Spike Mimetics for Vaccine Design.. Cell Rep.
Kong L, de la Peña ATorrents, Deller MC, Garces F, Sliepen K, Hua Y, Stanfield RL, Sanders RW, Wilson IA.  2015.  Complete epitopes for vaccine design derived from a crystal structure of the broadly neutralizing antibodies PGT128 and 8ANC195 in complex with an HIV-1 Env trimer.. Acta Crystallogr D Biol Crystallogr. 71(Pt 10):2099-108.
Derking R, Ozorowski G, Sliepen K, Yasmeen A, Cupo A, Torres JL, Julien J-P, Lee J H, van Montfort T, de Taeye SW et al..  2015.  Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer.. PLoS Pathog. 11(3):e1004767.
Edlefsen PT, Rolland M, Hertz T, Tovanabutra S, Gartland AJ, DeCamp AC, Magaret CA, Ahmed H, Gottardo R, Juraska M et al..  2015.  Comprehensive sieve analysis of breakthrough HIV-1 sequences in the RV144 vaccine efficacy trial.. PLoS Comput Biol. 11(2):e1003973.
He L, Zhu J.  2015.  Computational tools for epitope vaccine design and evaluation.. Curr Opin Virol. 11:103-112.
Ingale J, Wyatt RT.  2015.  Coupling of HIV-1 gp120-derived Core Protein to Paramagnetic Beads and Adsorption Assays.. Bio Protoc. 5(20)
Kong L, Wilson IA, Kwong PD.  2015.  Crystal structure of a fully glycosylated HIV-1 gp120 core reveals a stabilizing role for the glycan at Asn262.. Proteins. 83(3):590-6.
Stanfield RL, De Castro C, Marzaioli AM, Wilson IA, Pantophlet R.  2015.  Crystal structure of the HIV neutralizing antibody 2G12 in complex with a bacterial oligosaccharide analog of mammalian oligomannose.. Glycobiology. 25(4):412-9.
Julien J-P, Lee J H, Ozorowski G, Hua Y, de la Peña ATorrents, de Taeye SW, Nieusma T, Cupo A, Yasmeen A, Golabek M et al..  2015.  Design and structure of two HIV-1 clade C SOSIP.664 trimers that increase the arsenal of native-like Env immunogens.. Proc Natl Acad Sci U S A.
Bitto D, Harvey DJ, Halldorsson S, Doores KJ, Pritchard LK, Huiskonen JT, Bowden TA, Crispin M.  2015.  Determination of N-linked Glycosylation in Viral Glycoproteins by Negative Ion Mass Spectrometry and Ion Mobility.. Methods Mol Biol. 1331:93-121.
Murugan R, Imkeller K, Busse CE, Wardemann H.  2015.  Direct high-throughput amplification and sequencing of immunoglobulin genes from single human B cells.. Eur J Immunol. 45(9):2698-700.
Sliepen K, van Montfort T, Ozorowski G, Pritchard LK, Crispin M, Ward AB, Sanders RW.  2015.  Engineering and Characterization of a Fluorescent Native-Like HIV-1 Envelope Glycoprotein Trimer.. Biomolecules. 5(4):2919-34.
Heesters BA, Lindqvist M, Vagefi PA, Scully EP, Schildberg FA, Altfeld M, Walker BD, Kaufmann DE, Carroll MC.  2015.  Follicular Dendritic Cells Retain Infectious HIV in Cycling Endosomes.. PLoS Pathog. 11(12):e1005285.
Pritchard LK, Spencer DIR, Royle L, Bonomelli C, Seabright GE, Behrens A-J, Kulp DW, Menis S, Krumm SA, Dunlop CD et al..  2015.  Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies.. Nat Commun. 6:7479.
Pritchard LK, Spencer DIR, Royle L, Vasiljevic S, Krumm SA, Doores KJ, Crispin M.  2015.  Glycan Microheterogeneity at the PGT135 Antibody Recognition Site on HIV-1 gp120 Reveals a Molecular Mechanism for Neutralization Resistance.. J Virol. 89(13):6952-9.